UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current Status and Future Perspectives on MRNA Drug Manufacturing

Molecular pharmaceutics, 2022-04, Vol.19 (4), p.1047-1058

2022

Volltextzugriff (PDF)

Frailty is associated with increased waiting time for relevant process-of-care measures; findings from the Emergency Laparoscopic and Laparotomy Scottish audit (ELLSA)

British journal of surgery, 2022-02, Vol.109 (2), p.172-175

2022

Volltextzugriff (PDF)

Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis

PloS one, 2015-06, Vol.10 (6), p.e0128945-e0128945

2015

Volltextzugriff (PDF)

Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo

Annals of hematology, 2019-08, Vol.98 (8), p.1905-1918

2019

Volltextzugriff (PDF)

Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

Molecular cancer therapeutics, 2006-07, Vol.5 (7), p.1854-1863

2006

Volltextzugriff (PDF)

Poor outcomes in patients with sepsis undergoing emergency laparotomy and laparoscopy are attenuated by faster time to care measures

Colorectal disease, 2023-09, Vol.25 (9), p.1888-1895

2023

Volltextzugriff (PDF)

Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort study

BMC geriatrics, 2022-02, Vol.22 (1), p.119-119, Article 119

2022

Volltextzugriff (PDF)

Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications

Methods in molecular biology (Clifton, N.J.), 2014-01, Vol.1141, p.109

2014

Volltextzugriff (PDF)

Development of a liposomal nanoparticle formulation of 5-Fluorouracil for parenteral administration: Formulation design, pharmacokinetics and efficacy

Journal of controlled release, 2011-03, Vol.150 (2), p.212-219

2011

Volltextzugriff (PDF)

Irinophore C: A Liposome Formulation of Irinotecan with Substantially Improved Therapeutic Efficacy against a Panel of Human Xenograft Tumors

Clinical cancer research, 2008-02, Vol.14 (4), p.1208-1217

2008

Volltextzugriff (PDF)

Characterization of Cationic Liposome Formulations Designed to Exhibit Extended Plasma Residence Times and Tumor Vasculature Targeting Properties

Journal of pharmaceutical sciences, 2010-06, Vol.99 (6), p.2839-2853

2010

Volltextzugriff (PDF)

Liposomal irinotecan: Formulation development and therapeutic assessment in murine xenograft models of colorectal cancer

Clinical cancer research, 2004-10, Vol.10 (19), p.6638-6649

2004

Volltextzugriff (PDF)

Microfluidics: a transformational tool for nanomedicine development and production

Journal of drug targeting, 2016-11, Vol.24 (9), p.821-835

2016

Volltextzugriff (PDF)

Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin

Clinical cancer research, 2008-11, Vol.14 (22), p.7260-7271

2008

Volltextzugriff (PDF)

The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinations

Current drug delivery, 2005-10, Vol.2 (4), p.341-351

2005

Volltextzugriff (PDF)

Submicrometer photoresponse mapping of nanowire superconducting single-photon detectors

Applied physics letters, 2007-12, Vol.91 (24), p.241108-241108-3

2007

Volltextzugriff (PDF)

Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformation

Pharmaceutical research, 2006-12, Vol.23 (12), p.2799-2808

2006

Volltextzugriff (PDF)

Gene silencing in the development of personalized cancer treatment: the targets, the agents and the delivery systems

Current gene therapy, 2006-08, Vol.6 (4), p.505-533

2006

Volltextzugriff (PDF)

Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway : therapeutic implications for combination therapy with rapamycin

Breast cancer research and treatment, 2007-12, Vol.106 (3), p.319-331

2007

Volltextzugriff (PDF)

Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo

Annals of hematology, 2019-08, Vol.98 (8), p.1905-1918

2019

Volltextzugriff (PDF)

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in AML

Blood, 2019-11, Vol.134 (Supplement_1), p.2545-2545

2019

Volltextzugriff (PDF)

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia

Cancers, 2020-10, Vol.12 (10), p.2766

2020

Volltextzugriff (PDF)

A systematic methodology review of fluorescence-guided cancer surgery to inform the development of a core master protocol and outcome set

BMC cancer, 2024-06, Vol.24 (1), p.697-12

Vallance, Abigail E

2024

Volltextzugriff (PDF)

Flow imaging by use of femtosecond-laser-induced two-photon fluorescence

Optics letters, 2004-08, Vol.29 (16), p.1873

2004

Volltextzugriff (PDF)

RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo

Leukemia, 2018-01, Vol.32 (1), p.224-226

2018

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(31)
Humans
(20)
Animals
(19)
Mice
(15)
Biological And Medical Sciences
(14)
Liposomes
(12)
Medical Sciences
(12)
Pharmacology & Pharmacy
(12)
Physical Sciences
(12)
Pharmacology. Drug Treatments
(11)
Oncology
(10)
Female
(9)
Camptothecin - Analogs & Derivatives
(8)
Camptothecin - Administration & Dosage
(7)
General Pharmacology
(7)
Pharmaceutical Technology. Pharmaceutical Industry
(7)
Cancer
(6)
Antineoplastic Agents
(5)
Cell Line, Tumor
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Current Status and Future Perspectives on MRNA Drug Manufacturing

Frailty is associated with increased waiting time for relevant process-of-care measures; findings from the Emergency Laparoscopic and Laparotomy Scottish audit (ELLSA)

Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis

Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo

Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

Poor outcomes in patients with sepsis undergoing emergency laparotomy and laparoscopy are attenuated by faster time to care measures

Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort study

Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications

Development of a liposomal nanoparticle formulation of 5-Fluorouracil for parenteral administration: Formulation design, pharmacokinetics and efficacy

Irinophore C: A Liposome Formulation of Irinotecan with Substantially Improved Therapeutic Efficacy against a Panel of Human Xenograft Tumors

Characterization of Cationic Liposome Formulations Designed to Exhibit Extended Plasma Residence Times and Tumor Vasculature Targeting Properties

Liposomal irinotecan: Formulation development and therapeutic assessment in murine xenograft models of colorectal cancer

Microfluidics: a transformational tool for nanomedicine development and production

Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin

The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinations

Submicrometer photoresponse mapping of nanowire superconducting single-photon detectors

Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformation

Gene silencing in the development of personalized cancer treatment: the targets, the agents and the delivery systems

Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway : therapeutic implications for combination therapy with rapamycin

Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in AML

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia

A systematic methodology review of fluorescence-guided cancer surgery to inform the development of a core master protocol and outcome set

Flow imaging by use of femtosecond-laser-induced two-photon fluorescence

RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo

Suchergebnisse filtern